Bio-Techne Corp TECH

NAS: TECH | ISIN: US09073M1045   30/04/2025
50,35 USD (-0,30%)
(-0,30%)   30/04/2025

29 april 2025 · ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy · Persbericht

24 april 2025 · Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection · Persbericht

23 april 2025 · Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting · Persbericht

15 april 2025 · Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results · Persbericht

2 april 2025 · Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument · Persbericht

26 maart 2025 · Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany · Persbericht

24 maart 2025 · Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting · Persbericht

10 maart 2025 · Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System · Persbericht

3 maart 2025 · Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes · Persbericht

27 augustus 2024 · ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine · Persbericht

26 augustus 2024 · Bio-Techne To Present At Investor Healthcare Conferences · Persbericht

7 augustus 2024 · Bio-Techne Declares Dividend · Persbericht

7 augustus 2024 · Bio-Techne Releases Fourth Quarter Fiscal 2024 Results · Persbericht

31 juli 2024 · Bio-Techne Announces Next-Generation High Throughput Simple Western System · Persbericht

29 juli 2024 · Bio-Techne Announces Strategic Investment In Spear Bio · Persbericht

15 juli 2024 · Bio-Techne To Host Conference Call On August 7, 2024, To Announce Fourth Quarter And Fiscal 2024 Financial Results · Persbericht

31 mei 2024 · Bio-Techne To Present At Upcoming Investor Conferences · Persbericht

30 mei 2024 · BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE · Persbericht

29 mei 2024 · ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing · Persbericht

23 mei 2024 · Bio-Techne To Present At The 2024 Leerink Partners Healthcare Crossroads Conference · Persbericht

Mijn selecties